Cormorant Asset Management, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 28 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$11,928,000
-24.4%
200,0000.0%2.11%
-19.5%
Q2 2017$15,778,000
-4.9%
200,0000.0%2.62%
+8.6%
Q1 2017$16,588,000
-49.0%
200,000
-51.2%
2.41%
-45.1%
Q4 2016$32,529,000
+1.9%
410,000
-10.1%
4.38%
+24.6%
Q3 2016$31,920,000
+62.6%
455,995
-9.9%
3.52%
+26.5%
Q2 2016$19,628,000
-3.1%
505,995
+1.2%
2.78%
-8.8%
Q1 2016$20,250,000
-42.9%
500,000
+25.0%
3.05%
-28.1%
Q4 2015$35,468,000
+59.7%
400,000
+33.3%
4.24%
+19.6%
Q3 2015$22,209,000
-8.4%
300,0000.0%3.55%
+10.0%
Q2 2015$24,258,000
-19.2%
300,000
-58.1%
3.22%
-30.5%
Q1 2015$30,014,000
+384.1%
716,500
+79.1%
4.64%
+385.1%
Q4 2014$6,200,000
+22.5%
400,0000.0%0.96%
-8.2%
Q3 2014$5,060,000
-11.7%
400,0000.0%1.04%
-31.5%
Q2 2014$5,732,000
+12.4%
400,0000.0%1.52%
+29.5%
Q1 2014$5,100,000400,0001.17%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders